Fill finish manufacturing market size to increase by USD 5,774.96 million between 2022 and 2027; Growth driven by the increasing use of analytics by CDMOs – Technavio

The fill finish manufacturing market size is forecast to grow by USD 5,774.96 million between 2022 and 2027, and the growth momentum will accelerate at a CAGR of 10.22% during the forecast period. The growth of the market is driven by the increasing use of analytics by contract development and manufacturing organizations (CDMOs). The use of analytics is helping CDMOs in enhancing the productivity and efficiency of operations. Analytics solutions allow CDMOs to develop and utilize methods of making the development process more efficient. These solutions also improve communication between engineers, line operators, and managers, which, in turn, improves the decision-making process. All these factors are supporting the growth of the market in focus. For more insights on the historic data (2017 to 2021) and forecast market size (2023 to 2027) – Request a report sample

Technavio has announced its latest market research report titled Global Fill Finish Manufacturing Market 2023-2027
Technavio has announced its latest market research report titled Global Fill Finish Manufacturing Market 2023-2027

Regional Analysis

By region, the global fill finish manufacturing market is segmented into North America, Europe, Asia, and Rest of World (ROW). Asia will account for 41% of market growth during the forecast period. Factors such as improving healthcare infrastructure, increasing number of hospitals and retail pharmacies, and high penetration of generic drugs are driving the growth of the fill finish manufacturing market in Asia.

Company Profiles

The fill finish manufacturing market report includes information on the key products and recent developments of leading vendors, including:

  • Becton Dickinson and Co. – The company offers fill finish manufacturing products and services such as Prefillable syringe systems.
  • Biocon Ltd. – The company offers fill finish manufacturing products and services such as Sterile Fill Finish.
  • Fresenius SE and Co. KGaA – The company offers fill finish manufacturing products and services such as Contract Manufacturing for Fill and Finish Services and Medical Devices.
  • Gerresheimer AG – The company offers fill finish manufacturing products and services such as providing assistance with fill and finish processes.

Market Dynamics

The growth of the market is driven by factors such as the increasing use of analytics by CDMOs, improvements in hardware-related drawbacks, and improving customer support services. However, stringent government regulations for the approval of pharmacy automation systems will hinder the growth of the market.

Competitive Analysis

The competitive scenario categorizes companies based on various performance indicators. Some of the factors considered include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, and growth in market share among others. Request a Sample

Market Segmentation

  • By product, the market is segmented into consumables and instruments.
  • By end-user, the market is segmented into contract manufacturing organizations and biopharmaceutical companies.
  • By geography, the market is segmented into North America, Europe, Asia, and Rest of World (ROW).

Why Buy?

  • Add credibility to strategy
  • Analyzes competitor’s offerings
  • Get a holistic view of the market

Grow your profit margin with Technavio – Buy the Report!

Related Reports:

  • The liposomal products market is estimated to grow at a CAGR of 9.65% between 2022 and 2027. The size of the market is forecast to increase by USD 3,183.63 million. The rising incidence of fungal disorders is notably driving the market growth, although factors such as late diagnosis and poor survival of patients with cancer may impede the market growth.
  • The biologics CDMO market is estimated to grow at a CAGR of 13.97% between 2022 and 2027. The size of the market is forecast to increase by USD 13.26 billion. The strong research and development pipeline of biologics therapeutics is notably driving the market growth, although factors such as capacity utilization and constraints may impede the market growth.

Technavio’s library includes over 17,000+ reports, covering more than 2,000 emerging technologies. Subscribe to our “Basic Plan” at just USD 5,000 and get lifetime access to Technavio Insights

What are the key data covered in this fill finish manufacturing market report?

  • CAGR of the market during the forecast period.
  • Detailed information on factors that will drive the growth of the market between 2023 and 2027
  • Precise estimation of the size of the fill finish manufacturing market and its contribution to the parent market.
  • Accurate predictions about upcoming trends and changes in consumer behavior.
  • Growth of the market across North America, Europe, Asia, and Rest of World (ROW).
  • A thorough analysis of the market’s competitive landscape and detailed information about vendors.
  • Comprehensive analysis of factors that will challenge the growth of fill finish manufacturing market vendors.
Fill Finish Manufacturing Market Scope
Report CoverageDetails
Page number154
Base year2022
Historic period2017-2021
Forecast period2023-2027
Growth momentum & CAGRAccelerate at a CAGR of 10.22%
Market growth 2023-2027USD 5,774.96 million
Market structureFragmented
YoY growth 2022-2023 (%)9.56
Regional analysisAsia, North America, Europe, and Rest of World (ROW)
Performing market contributionAsia at 41%
Key countriesUS, Canada, Germany, UK, and China
Competitive landscapeLeading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks
Key companies profiledAbbVie Inc., Asymchem Inc., BAUSCH Advanced Technology Group, Becton Dickinson and Co., Biocon Ltd., Catalent Inc., Fresenius SE and Co. KGaA, Gerresheimer AG, groninger and co. gmbh, IMA Industria Macchine Automatiche Spa, Maquinaria Industrial Dara SL, Merck KGaA, Nipro Pharma Packaging International NV, OPTIMA packaging group GmbH, Recipharm AB, SCHOTT AG, Syntegon Technology GmbH, Thermo Fisher Scientific Inc., Vetter Pharma Fertigung GmbH and Co. KG, West Pharmaceutical Services Inc., and WuXi Biologics Cayman Inc.
Market dynamicsParent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and market condition analysis for the forecast period.
Customization purviewIf our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Browse through Technavio’s Health Care Market Reports

Table of contents:

1 Executive Summary

  • 1.1 Market overview 
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem 
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition 
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis 
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
  • 3.4 Market outlook: Forecast for 2022-2027 
    • Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
    • Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
    • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
    • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

  • 4.1 Global fill finish manufacturing market 2017 – 2021
    • Exhibit 18: Historic Market Size – Data Table on Global fill finish manufacturing market 2017 – 2021 ($ million)
  • 4.2 Product Segment Analysis 2017 – 2021 
    • Exhibit 19: Historic Market Size – Product Segment 2017 – 2021 ($ million)
  • 4.3 End-user Segment Analysis 2017 – 2021 
    • Exhibit 20: Historic Market Size – End-user Segment 2017 – 2021 ($ million)
  • 4.4 Geography Segment Analysis 2017 – 2021 
    • Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
  • 4.5 Country Segment Analysis 2017 – 2021 
    • Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary 
    • Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
  • 5.2 Bargaining power of buyers 
    • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
  • 5.3 Bargaining power of suppliers 
    • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
  • 5.4 Threat of new entrants 
    • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
  • 5.5 Threat of substitutes 
    • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
  • 5.6 Threat of rivalry 
    • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
  • 5.7 Market condition 
    • Exhibit 29: Chart on Market condition – Five forces 2022 and 2027

6 Market Segmentation by Product

  • 6.1 Market segments 
    • Exhibit 30: Chart on Product – Market share 2022-2027 (%)
    • Exhibit 31: Data Table on Product – Market share 2022-2027 (%)
  • 6.2 Comparison by Product 
    • Exhibit 32: Chart on Comparison by Product
    • Exhibit 33: Data Table on Comparison by Product
  • 6.3 Consumables – Market size and forecast 2022-2027
    • Exhibit 34: Chart on Consumables – Market size and forecast 2022-2027 ($ million)
    • Exhibit 35: Data Table on Consumables – Market size and forecast 2022-2027 ($ million)
    • Exhibit 36: Chart on Consumables – Year-over-year growth 2022-2027 (%)
    • Exhibit 37: Data Table on Consumables – Year-over-year growth 2022-2027 (%)
  • 6.4 Instruments – Market size and forecast 2022-2027
    • Exhibit 38: Chart on Instruments – Market size and forecast 2022-2027 ($ million)
    • Exhibit 39: Data Table on Instruments – Market size and forecast 2022-2027 ($ million)
    • Exhibit 40: Chart on Instruments – Year-over-year growth 2022-2027 (%)
    • Exhibit 41: Data Table on Instruments – Year-over-year growth 2022-2027 (%)
  • 6.5 Market opportunity by Product 
    • Exhibit 42: Market opportunity by Product ($ million)
    • Exhibit 43: Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by End-user

  • 7.1 Market segments 
    • Exhibit 44: Chart on End-user – Market share 2022-2027 (%)
    • Exhibit 45: Data Table on End-user – Market share 2022-2027 (%)
  • 7.2 Comparison by End-user 
    • Exhibit 46: Chart on Comparison by End-user
    • Exhibit 47: Data Table on Comparison by End-user
  • 7.3 Contract manufacturing organizations – Market size and forecast 2022-2027 
    • Exhibit 48: Chart on Contract manufacturing organizations – Market size and forecast 2022-2027 ($ million)
    • Exhibit 49: Data Table on Contract manufacturing organizations – Market size and forecast 2022-2027 ($ million)
    • Exhibit 50: Chart on Contract manufacturing organizations – Year-over-year growth 2022-2027 (%)
    • Exhibit 51: Data Table on Contract manufacturing organizations – Year-over-year growth 2022-2027 (%)
  • 7.4 Biopharmaceutical companies – Market size and forecast 2022-2027 
    • Exhibit 52: Chart on Biopharmaceutical companies – Market size and forecast 2022-2027 ($ million)
    • Exhibit 53: Data Table on Biopharmaceutical companies – Market size and forecast 2022-2027 ($ million)
    • Exhibit 54: Chart on Biopharmaceutical companies – Year-over-year growth 2022-2027 (%)
    • Exhibit 55: Data Table on Biopharmaceutical companies – Year-over-year growth 2022-2027 (%)
  • 7.5 Market opportunity by End-user 
    • Exhibit 56: Market opportunity by End-user ($ million)
    • Exhibit 57: Data Table on Market opportunity by End-user ($ million)

8 Customer Landscape

  • 8.1 Customer landscape overview 
    • Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation 
    • Exhibit 59: Chart on Market share by geography 2022-2027 (%)
    • Exhibit 60: Data Table on Market share by geography 2022-2027 (%)
  • 9.2 Geographic comparison 
    • Exhibit 61: Chart on Geographic comparison
    • Exhibit 62: Data Table on Geographic comparison
  • 9.3 Asia – Market size and forecast 2022-2027
    • Exhibit 63: Chart on Asia – Market size and forecast 2022-2027 ($ million)
    • Exhibit 64: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
    • Exhibit 65: Chart on Asia – Year-over-year growth 2022-2027 (%)
    • Exhibit 66: Data Table on Asia – Year-over-year growth 2022-2027 (%)
  • 9.4 North America – Market size and forecast 2022-2027
    • Exhibit 67: Chart on North America – Market size and forecast 2022-2027 ($ million)
    • Exhibit 68: Data Table on North America – Market size and forecast 2022-2027 ($ million)
    • Exhibit 69: Chart on North America – Year-over-year growth 2022-2027 (%)
    • Exhibit 70: Data Table on North America – Year-over-year growth 2022-2027 (%)
  • 9.5 Europe – Market size and forecast 2022-2027
    • Exhibit 71: Chart on Europe – Market size and forecast 2022-2027 ($ million)
    • Exhibit 72: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
    • Exhibit 73: Chart on Europe – Year-over-year growth 2022-2027 (%)
    • Exhibit 74: Data Table on Europe – Year-over-year growth 2022-2027 (%)
  • 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
    • Exhibit 75: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
    • Exhibit 76: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
    • Exhibit 77: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
    • Exhibit 78: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
  • 9.7 China – Market size and forecast 2022-2027
    • Exhibit 79: Chart on China – Market size and forecast 2022-2027 ($ million)
    • Exhibit 80: Data Table on China – Market size and forecast 2022-2027 ($ million)
    • Exhibit 81: Chart on China – Year-over-year growth 2022-2027 (%)
    • Exhibit 82: Data Table on China – Year-over-year growth 2022-2027 (%)
  • 9.8 US – Market size and forecast 2022-2027
    • Exhibit 83: Chart on US – Market size and forecast 2022-2027 ($ million)
    • Exhibit 84: Data Table on US – Market size and forecast 2022-2027 ($ million)
    • Exhibit 85: Chart on US – Year-over-year growth 2022-2027 (%)
    • Exhibit 86: Data Table on US – Year-over-year growth 2022-2027 (%)
  • 9.9 Germany – Market size and forecast 2022-2027
    • Exhibit 87: Chart on Germany – Market size and forecast 2022-2027 ($ million)
    • Exhibit 88: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
    • Exhibit 89: Chart on Germany – Year-over-year growth 2022-2027 (%)
    • Exhibit 90: Data Table on Germany – Year-over-year growth 2022-2027 (%)
  • 9.10 Canada – Market size and forecast 2022-2027
    • Exhibit 91: Chart on Canada – Market size and forecast 2022-2027 ($ million)
    • Exhibit 92: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
    • Exhibit 93: Chart on Canada – Year-over-year growth 2022-2027 (%)
    • Exhibit 94: Data Table on Canada – Year-over-year growth 2022-2027 (%)
  • 9.11 UK – Market size and forecast 2022-2027
    • Exhibit 95: Chart on UK – Market size and forecast 2022-2027 ($ million)
    • Exhibit 96: Data Table on UK – Market size and forecast 2022-2027 ($ million)
    • Exhibit 97: Chart on UK – Year-over-year growth 2022-2027 (%)
    • Exhibit 98: Data Table on UK – Year-over-year growth 2022-2027 (%)
  • 9.12 Market opportunity by geography 
    • Exhibit 99: Market opportunity by geography ($ million)
    • Exhibit 100: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges 
    • Exhibit 101: Impact of drivers and challenges in 2022 and 2027
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape 
    • Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption 
    • Exhibit 103: Overview on factors of disruption
  • 11.4 Industry risks 
    • Exhibit 104: Impact of key risks on business

12 Vendor Analysis

  • 12.1 Vendors covered 
    • Exhibit 105: Vendors covered
  • 12.2 Market positioning of vendors 
    • Exhibit 106: Matrix on vendor position and classification
  • 12.3 AbbVie Inc. 
    • Exhibit 107: AbbVie Inc. – Overview
    • Exhibit 108: AbbVie Inc. – Product / Service
    • Exhibit 109: AbbVie Inc. – Key news
    • Exhibit 110: AbbVie Inc. – Key offerings
  • 12.4 Becton Dickinson and Co. 
    • Exhibit 111: Becton Dickinson and Co. – Overview
    • Exhibit 112: Becton Dickinson and Co. – Business segments
    • Exhibit 113: Becton Dickinson and Co. – Key news
    • Exhibit 114: Becton Dickinson and Co. – Key offerings
    • Exhibit 115: Becton Dickinson and Co. – Segment focus
  • 12.5 Biocon Ltd. 
    • Exhibit 116: Biocon Ltd. – Overview
    • Exhibit 117: Biocon Ltd. – Business segments
    • Exhibit 118: Biocon Ltd. – Key offerings
    • Exhibit 119: Biocon Ltd. – Segment focus
  • 12.6 Fresenius SE and Co. KGaA 
    • Exhibit 120: Fresenius SE and Co. KGaA – Overview
    • Exhibit 121: Fresenius SE and Co. KGaA – Business segments
    • Exhibit 122: Fresenius SE and Co. KGaA – Key news
    • Exhibit 123: Fresenius SE and Co. KGaA – Key offerings
    • Exhibit 124: Fresenius SE and Co. KGaA – Segment focus
  • 12.7 Gerresheimer AG 
    • Exhibit 125: Gerresheimer AG – Overview
    • Exhibit 126: Gerresheimer AG – Business segments
    • Exhibit 127: Gerresheimer AG – Key news
    • Exhibit 128: Gerresheimer AG – Key offerings
    • Exhibit 129: Gerresheimer AG – Segment focus
  • 12.8 groninger and co. gmbh 
    • Exhibit 130: groninger and co. gmbh – Overview
    • Exhibit 131: groninger and co. gmbh – Product / Service
    • Exhibit 132: groninger and co. gmbh – Key offerings
  • 12.9 IMA Industria Macchine Automatiche Spa
    • Exhibit 133: IMA Industria Macchine Automatiche Spa – Overview
    • Exhibit 134: IMA Industria Macchine Automatiche Spa – Business segments
    • Exhibit 135: IMA Industria Macchine Automatiche Spa – Key news
    • Exhibit 136: IMA Industria Macchine Automatiche Spa – Key offerings
    • Exhibit 137: IMA Industria Macchine Automatiche Spa – Segment focus
  • 12.10 Maquinaria Industrial Dara SL 
    • Exhibit 138: Maquinaria Industrial Dara SL – Overview
    • Exhibit 139: Maquinaria Industrial Dara SL – Product / Service
    • Exhibit 140: Maquinaria Industrial Dara SL – Key offerings
  • 12.11 Merck KGaA 
    • Exhibit 141: Merck KGaA – Overview
    • Exhibit 142: Merck KGaA – Business segments
    • Exhibit 143: Merck KGaA – Key news
    • Exhibit 144: Merck KGaA – Key offerings
    • Exhibit 145: Merck KGaA – Segment focus
  • 12.12 Nipro Pharma Packaging International NV
    • Exhibit 146: Nipro Pharma Packaging International NV – Overview
    • Exhibit 147: Nipro Pharma Packaging International NV – Business segments
    • Exhibit 148: Nipro Pharma Packaging International NV – Key news
    • Exhibit 149: Nipro Pharma Packaging International NV – Key offerings
    • Exhibit 150: Nipro Pharma Packaging International NV – Segment focus
  • 12.13 OPTIMA packaging group GmbH 
    • Exhibit 151: OPTIMA packaging group GmbH – Overview
    • Exhibit 152: OPTIMA packaging group GmbH – Product / Service
    • Exhibit 153: OPTIMA packaging group GmbH – Key offerings
  • 12.14 Recipharm AB 
    • Exhibit 154: Recipharm AB – Overview
    • Exhibit 155: Recipharm AB – Business segments
    • Exhibit 156: Recipharm AB – Key offerings
    • Exhibit 157: Recipharm AB – Segment focus
  • 12.15 SCHOTT AG 
    • Exhibit 158: SCHOTT AG – Overview
    • Exhibit 159: SCHOTT AG – Business segments
    • Exhibit 160: SCHOTT AG – Key news
    • Exhibit 161: SCHOTT AG – Key offerings
    • Exhibit 162: SCHOTT AG – Segment focus
  • 12.16 Syntegon Technology GmbH 
    • Exhibit 163: Syntegon Technology GmbH – Overview
    • Exhibit 164: Syntegon Technology GmbH – Product / Service
    • Exhibit 165: Syntegon Technology GmbH – Key offerings
  • 12.17 Thermo Fisher Scientific Inc. 
    • Exhibit 166: Thermo Fisher Scientific Inc. – Overview
    • Exhibit 167: Thermo Fisher Scientific Inc. – Business segments
    • Exhibit 168: Thermo Fisher Scientific Inc. – Key news
    • Exhibit 169: Thermo Fisher Scientific Inc. – Key offerings
    • Exhibit 170: Thermo Fisher Scientific Inc. – Segment focus

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist 
    • Exhibit 171: Inclusions checklist
    • Exhibit 172: Exclusions checklist
  • 13.3 Currency conversion rates for US$ 
    • Exhibit 173: Currency conversion rates for US$
  • 13.4 Research methodology 
    • Exhibit 174: Research methodology
    • Exhibit 175: Validation techniques employed for market sizing
    • Exhibit 176: Information sources
  • 13.5 List of abbreviations 
    • Exhibit 177: List of abbreviations

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio

Leave a Reply

Your email address will not be published.